Corticosteroid therapy for nephrotic syndrome in children-Reference-Cited by-同舟云学术

Corticosteroid therapy for nephrotic syndrome in children

Published:2024-08-22 Issue:8 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hahn Deirdre¹,Samuel Susan M²,Willis Narelle S³⁴,Craig Jonathan C⁴⁵,Hodson Elisabeth M⁴

Affiliation:

1. Department of Nephrology; The Children's Hospital at Westmead; Westmead Australia

2. Department of Pediatrics; University of Calgary; Calgary Canada

3. Sydney School of Public Health; The University of Sydney; Sydney Australia

4. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

5. College of Medicine and Public Health; Flinders University; Adelaide Australia

Publisher

Wiley

Reference178 articles.

1. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial;Abeyagunawardena;Archives of Disease in Childhood,2008

2. A short course of prednisolone during an upper respiratory tract infection reduces the risk of relapse in childhood nephrotic syndrome [abstract no: P12];Abeyagunawardena;Pediatric Nephrology,2014

3. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome;Abeyagunawardena;Pediatric Nephrology,2017

4. Short course of daily prednisolone during upper respiratory tract infection reduces the risk of relapse in childhood nephrotic syndrome [abstract no: G376(P)];Abeyagunawardena;Archives of Disease in Childhood,2014

5. Open randomized clinical study to evaluate efficacy and safety of deflazacort versus prednisolone in idiopathic nephrotic syndrome [abstract no: 558];Agarwal;Pediatric Nephrology,2010